|
Say, "Brain Damage" and most
people think of trauma to the brain. There is a
greater cause of Brain Damage in
humans, "neurotoxins". Neurotoxins are chemicals
in the environment
which get into the brain and cause permanent
irreversible Attention Disorders. A list of over 1,100
neurotoxins that cause Brain Damage
is found on the "neurotoxins" link in the left
column.
There are over 100 diseases that are caused by
or associated with the neurotransmitters
serotonin, dopamine, norepinephrine, and
epinephrine. A few of these diseases are
depression, anxiety, panic attacks, insomnia,
PMS, OCD, obesity, etc. Common thinking in
medicine is that these diseases are caused by,
"low levels of neurotransmitters". NeuroResearch
Clinics has discovered that this is not the
case. Through neurotransmitter testing research
NeuroResearch Clinics has determined that a group
of patients suffering from a neurotransmitter
disease has virtually identical
neurotransmitter levels to patients with no
disease. If low levels of neurotransmitters that
cause disease then what does? The answer is
Brain Damage.
Why is the incidence of depression, attention
deficit disorder, obesity, obsessive compulsive
disorder and other neurotransmitter diseases
greater in developed countries than undeveloped
countries. Why have the incidence of these
diseases increased in recent decades. It is no
coincidence that as more neurotoxic chemicals
are used the incidence of neurotransmitter
disease increases.
For some reason few have made the connection
between neurotoxic chemicals, chronic
depression, chronic anxiety and the other
neurotransmitter diseases. When
there is enough Brain Damage from neurotoxins chronic disease sets
in.
Parkinson's disease is a prototype disease for
neurotoxic Brain Damage.
Establishing neurotransmitter levels in the
normal range does nothing to relieve Parkinson's
symptoms. The same is true for the other
neurotransmitter diseases. Neurotransmitter levels higher than normal need to be established in
order to compensate for the structural
Brain Damage impeding electrical flow in
the brain.
Patients with Brain Damage from
neurotoxicity who are experiencing disease
symptoms are suffering from impaired flow of
electricity in the brain. The only way to
control these symptoms is to increase
neurotransmitter levels above the normal range
causing additional electricity to flow through structures with
Brain Damage.
It is not low levels of neurotransmitters in the
brain that is the primary cause of
neurotransmitter disease. It is
neurotransmitter levels that are not high enough
to compensate for Brain Damage
from neurotoxins or other insult.
While the focus of this article is Brain
Damage from neurotoxins, NeuroResearch
clinics has developed research data showing that
some patients with traumatic brain injury can
show profound results with the neurotransmitter
optimization approach developed by
NeuroResearch. Attention Disorders is Attention
Disorders, the cause not
as important as realizing symptoms can be
reversed.
It
is
no secret NeuroResearch Clinics uses
the nutrients 5-HTP, tyrosine,
levodopa,
and cysteine with neurotransmitter testing as indicated to treat
Attention Deficit (ADD ADHD)
patients in order to achieve the results
that are documented by our doctors, Proper
use of these simple nutrients in
medical treatment is not simple.
From time to time a patient will
say, "Why do I want to take that, I
can go to a health food store and
buy it?" People off the street
buying in a health food store is
like going to an art store and
buying a bunch of oil paints then
going home and expecting to paint
like a mater artist even though
there was no previous painting
experience. Due to their unique
chemical properties nutrients have
tremendous potential. The potential
is only fully realized in the hands
of the fully trained professional using
neurotransmitter testing. Treatment
is not just giving a nutrient pill, it is the whole medical approach
doctors are trained in to manage the
disease properly and make sure that
that the treatment plan is on track
to get symptoms under control.
The Peer Reviewed Research of
NeuroResearch Clinics
The research findings of NeuroResearch Clinics
have not been ignored. The University of
Minnesota Medical School is writing a series of
papers on the neurotransmitter testing research of NeuroResearch Clinics. The first of a series of papers by University of Minnesota Medical School based on the neurotransmitter testing research of NeuroResearch was published in "NeuroPsychiatric Disease and Treatment" May 1, 2009. Ingrid
Kohlstadt, MD of Johns Hopkins in her new
medical text book released February 7, 2009
included a chapter on depression written by
Marty L. Hinz, MD President Clinical
Research NeuroResearch Clinics outlining in
depth the proper use of amino acids and
neurotransmitter testing in treatment of
depression.
research |
